Vertex Pharmaceuticals Inc / Ma

CAPSTONE INVESTMENT ADVISORS, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

3,239

Value ($000)

1,468

Weight

0.0%

2020 Q4 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,468	0.0%	3,239	12/31/2025
2025 Q3	11/14/2025	2,359	0.0%	6,023	9/30/2025
2025 Q2	8/14/2025	1,050	0.0%	2,359	6/30/2025
2024 Q4	2/14/2025	3,214	0.0%	7,980	12/31/2024
2024 Q3	11/14/2024	405	0.0%	870	9/30/2024
2024 Q1	5/1/2024	1,822	0.0%	4,359	3/31/2024
2023 Q4	2/12/2024	548	0.0%	1,346	12/31/2023
2023 Q1	5/9/2023	965	0.0%	3,063	3/31/2023
2022 Q4	2/10/2023	280	0.0%	969	12/31/2022
2022 Q2	8/15/2022	336	0.0%	1,193	6/30/2022
2022 Q1	5/13/2022	0	0.0%	1	3/31/2022
2021 Q4	2/11/2022	2,648	0.0%	12,060	12/31/2021
2021 Q3	11/15/2021	18,378	0.3%	101,316	9/30/2021
2021 Q2	2/11/2022	7,142	0.2%	35,422	6/30/2021
2021 Q1	2/11/2022	2,709	0.1%	12,608	3/31/2021
2020 Q4	6/21/2021	7,583	0.2%	32,087	12/31/2020